Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STYX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | RP5-862P8.2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
mRNA | FAM63A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | G6PC3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | AC023283.1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
mRNA | ITGAM | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
mRNA | ADAM32 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
mRNA | OAS1 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
mRNA | NIT1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | TBC1D24 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |